Charlotte Magdelaine-Beuzelin Selected Research

Therapeutics

3/2010	Therapeutic antibodies in ophthalmology: old is new again.
11/2009	Influence of trough serum levels and immunogenicity on long-term outcome of adalimumab therapy in Crohn's disease.
6/2008	Withdrawal of immunosuppression in Crohn's disease treated with scheduled infliximab maintenance: a randomized trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Charlotte Magdelaine-Beuzelin Research Topics

Disease

3	Crohn Disease (Crohn's Disease) 11/2009 - 06/2008
2	Rheumatoid Arthritis 04/2010 - 01/2009
2	Neoplasms (Cancer) 03/2010 - 12/2007
1	Diphtheria 03/2010
1	Macular Degeneration (Age-Related Maculopathy) 03/2010
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 08/2008
1	Body Weight (Weight, Body) 08/2008
1	Thrombocytopenia (Thrombopenia) 11/2004

Drug/Important Bio-Agent (IBA)

5	Infliximab (Remicade)FDA Link 04/2010 - 06/2008
2	Monoclonal AntibodiesIBA 04/2010 - 12/2007
2	Bevacizumab (Avastin)FDA Link 03/2010 - 12/2007
2	AntibodiesIBA 12/2007 - 11/2004
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2010
1	Ranibizumab (Lucentis)FDA Link 03/2010
1	AntitoxinsIBA 03/2010
1	Adalimumab (Humira)FDA Link 11/2009
1	Immunoglobulin Variable RegionIBA 12/2007
1	Trastuzumab (Herceptin)FDA Link 12/2007
1	Alemtuzumab (Campath)FDA Link 12/2007
1	Cetuximab (Erbitux)FDA Link 12/2007
1	Rituximab (Mabthera)FDA Link 12/2007
1	Fc gamma receptor IIAIBA 11/2004
1	Immunoglobulin G (IgG)IBA 11/2004
1	Platelet Factor 4IBA 11/2004
1	Heparin (Liquaemin)FDA LinkGeneric 11/2004

Therapy/Procedure

3	Therapeutics 03/2010 - 06/2008